Published in Br J Cancer on September 18, 2007
Cancer survival in England and Wales at the end of the 20th century. Br J Cancer (2008) 4.18
Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer (2010) 2.07
Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes (2009) 2.05
Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer (2008) 1.89
Education, survival and avoidable deaths in cancer patients in Finland. Br J Cancer (2010) 1.21
No socioeconomic inequalities in colorectal cancer survival within a randomised clinical trial. Br J Cancer (2008) 1.00
Trends in skin cancer incidence by socioeconomic position in Scotland, 1978-2004. Br J Cancer (2010) 0.97
The impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: a population-based study. Br J Cancer (2012) 0.89
Socio-economic inequalities in survival of patients with prostate cancer: role of age and Gleason grade at diagnosis. PLoS One (2013) 0.83
Cancer survival in New South Wales, Australia: socioeconomic disparities remain despite overall improvements. BMC Cancer (2016) 0.81
Associations of Demographic and Socioeconomic Factors with Complete Treatment and Follow-up of Colon Cancer. Iran J Cancer Prev (2012) 0.80
No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials. Br J Cancer (2014) 0.77
Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 12.55
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst (2002) 9.45
Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin (1950) 7.94
Analysis of categorical data by linear models. Biometrics (1969) 7.85
Relative survival and the estimation of net survival: elements for further discussion. Stat Med (1990) 4.41
Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA (1994) 4.39
Deprivation indices: their interpretation and use in relation to health. J Epidemiol Community Health (1995) 4.09
Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol (2005) 4.07
Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer (2004) 4.06
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88
Socioeconomic status and stage at presentation of colorectal cancer. Lancet (1998) 3.16
Deprivation, stage at diagnosis and cancer survival. Int J Cancer (1995) 2.50
Socioeconomic differences in cancer survival: a review of the evidence. IARC Sci Publ (1997) 2.33
Socioeconomic status and cancer survival in Ontario. J Clin Oncol (1997) 2.32
Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ (1997) 2.08
Socioeconomic deprivation, travel distance, location of service, and uptake of breast cancer screening in North Derbyshire, UK. J Epidemiol Community Health (2006) 2.02
Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res (2001) 1.73
Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. Br J Cancer (2005) 1.66
Impact of deprivation and rural residence on treatment of colorectal and lung cancer. Br J Cancer (2002) 1.55
Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet (2002) 1.53
Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health (2004) 1.42
Socioeconomic variation in cancer survival in the southeastern Netherlands, 1980-1989. Cancer (1995) 1.42
Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer. Br J Surg (2002) 1.39
Socioeconomic status and comorbidity among newly diagnosed cancer patients. Cancer (1997) 1.38
Colon cancer in France: evidence for improvement in management and survival. Gut (2002) 1.34
Rising incidence of prostate cancer in Scotland: increased risk or increased detection? BJU Int (2000) 1.27
Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia. Br J Cancer (2006) 1.11
Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol (2005) 1.11
Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival. J Epidemiol Community Health (2003) 1.09
Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998. BJU Int (2000) 1.09
Explaining inequalities in access to treatment in lung cancer. J Eval Clin Pract (2006) 1.06
A population-based study from New South Wales, Australia 1996-2001: area variation in survival from colorectal cancer. Eur J Cancer (2005) 0.98
Incidence trends of prostate cancer in East Anglia, before and during the era of PSA diagnostic testing. Br J Cancer (2006) 0.96
Individual and regional determinants of mammography uptake. Can J Public Health (2004) 0.93
Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994). Eur J Cancer (2005) 0.92
Impact of a programme of mass mammography screening for breast cancer on socio-economic variation in survival: a population-based study. Breast Cancer Res Treat (2007) 0.86
What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer (2009) 4.31
Cancer survival in England and Wales at the end of the 20th century. Br J Cancer (2008) 4.18
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci (2001) 4.10
Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol (2005) 4.07
Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer (2004) 4.06
How many deaths have been avoided through improvements in cancer survival? BMJ (2000) 3.68
Excess mortality in England and Wales, and in Greater London, during the 1995 heatwave. J Epidemiol Community Health (1998) 3.67
Trends in cancer incidence and mortality. IARC Sci Publ (1993) 3.19
The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study. Br J Cancer (1988) 3.07
Risk of malignancy among patients with rheumatic conditions. Int J Cancer (2000) 2.70
The completeness of cancer registration in follow-up studies--a cautionary note. Br J Cancer (1987) 2.66
Why is mortality higher in Scotland than in England and Wales? Decreasing influence of socioeconomic deprivation between 1981 and 2001 supports the existence of a 'Scottish Effect'. J Public Health (Oxf) (2005) 2.58
Deprivation, stage at diagnosis and cancer survival. Int J Cancer (1995) 2.50
A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A (2000) 2.40
Deprivation and survival from breast cancer. Br J Cancer (1995) 2.27
Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax (2001) 2.24
Lung cancer: the importance of seeing a respiratory physician. Eur Respir J (2003) 2.08
Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer (2010) 2.07
Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J Epidemiol Community Health (2001) 2.01
Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst (1985) 2.00
Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer (2003) 1.79
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Completeness of cancer registration: a new method for routine use. Br J Cancer (2000) 1.75
Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England. Br J Cancer (2009) 1.74
'Cure' from breast cancer among two populations of women followed for 23 years after diagnosis. Ann Oncol (2009) 1.73
Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol (2011) 1.72
Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer (2001) 1.72
Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen (2010) 1.69
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. Cell Death Differ (2006) 1.68
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. Br J Cancer (2005) 1.66
Toward a comparison of survival in American and European cancer patients. Cancer (2000) 1.63
Cancer information under threat: the case for legislation. Ann Oncol (2001) 1.49
Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology (2003) 1.47
Testicular cancer in Europe and the USA: survival still rising among older patients. Ann Oncol (2012) 1.45
Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut (2011) 1.45
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. Br J Cancer (2013) 1.42
Survival from adult leukaemia in England and Wales up to 2001. Br J Cancer (2008) 1.41
Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group. Int J Cancer (1998) 1.41
Mortality from dementia in occupations at risk of exposure to bovine spongiform encephalopathy: analysis of death registrations. BMJ (1999) 1.38
Trends in biliary tract cancer. Rev Epidemiol Sante Publique (1993) 1.38
Risk of leukaemia among children living near the Solway coast of Dumfries and Galloway Health Board area, Scotland, 1975-2002. Occup Environ Med (2006) 1.38
Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer (1987) 1.37
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer (2003) 1.32
Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer (2008) 1.29
Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst (1987) 1.28
Trends in breast cancer incidence, survival, and mortality. Lancet (2000) 1.27
European health systems and cancer care. Ann Oncol (2003) 1.27
Opinion: why the variation in breast cancer survival in Europe? Breast Cancer Res (1999) 1.26
Trends in thyroid cancer incidence in Sweden, 1958-1981, by histopathologic type. Int J Cancer (1991) 1.23
Basic issues in estimating and comparing the survival of cancer patients. IARC Sci Publ (1995) 1.21
Improvements in survival for women with breast cancer in Scotland between 1987 and 1993: impact of earlier diagnosis and changes in treatment. Eur J Cancer (2004) 1.20
Mortality among male anaesthetists in the United Kingdom, 1957-83. Br Med J (Clin Res Ed) (1987) 1.18
The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer (2012) 1.17
Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol (2001) 1.13
Survival after acute lymphocytic leukaemia: effects of socioeconomic status and geographic region. Arch Dis Child (1999) 1.10
Survival from cancer of the pancreas in England and Wales up to 2001. Br J Cancer (2008) 1.10
Survival from cancer of the larynx in England and Wales up to 2001. Br J Cancer (2008) 1.08
The role of cancer registries. Clin Oncol (R Coll Radiol) (1995) 1.07
The journey towards a cancer diagnosis: the experiences of people with cancer, their family and carers. Eur J Cancer Care (Engl) (2003) 1.05
Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer (2005) 1.04
Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer (2003) 1.02
Survival from cancer of the oesophagus in England and Wales up to 2001. Br J Cancer (2008) 1.01
Predicted trends in long-term breast cancer survival in England and Wales. Br J Cancer (2007) 1.01
Survival from cancer of the colon in England and Wales up to 2001. Br J Cancer (2008) 1.01
Survival from cancer of the rectum in England and Wales up to 2001. Br J Cancer (2008) 1.01
No socioeconomic inequalities in colorectal cancer survival within a randomised clinical trial. Br J Cancer (2008) 1.00
Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines. Br J Cancer (2010) 1.00
Multiple primary malignant neoplasms in England and Wales, 1971-1981. Yale J Biol Med (1987) 0.99
Routinely collected data in national and regional databases--an under-used resource. J Public Health Med (1997) 0.98
The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Gastroenterology (1994) 0.98
Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study. Br J Cancer (2004) 0.98
Trends in skin cancer incidence by socioeconomic position in Scotland, 1978-2004. Br J Cancer (2010) 0.97
Would compliance with cancer care standards improve survival for breast, colorectal and lung cancers? J Epidemiol Community Health (2008) 0.97
Mortality from dementias and neurodegenerative disorders in people aged 15-64 in England and Wales in 1979-96. BMJ (1998) 0.97
[Intractable postpartum haemorrhages: where is the place of vascular ligations, emergency peripartum hysterectomy or arterial embolization?]. Gynecol Obstet Fertil (2004) 0.97
Increasing incidence of childhood leukaemia: a controversy re-examined. Br J Cancer (2007) 0.96
Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968-1998. Eur J Cancer (2003) 0.96
Geographical variation in breast cancer survival rates for women diagnosed in England between 1992 and 1994. Br J Cancer (2004) 0.96
Second primary malignancies in patients with male breast cancer. Br J Cancer (2005) 0.96
Genetic mapping of a cone and rod dysfunction (Aland Island eye disease) to the proximal short arm of the human X chromosome. J Med Genet (1993) 0.95
Survival from cancer of the ovary in England and Wales up to 2001. Br J Cancer (2008) 0.95